As FDA continues to evaluate regulatory frameworks for CBD, the states have emerged as the key regulators of the popular ingredient.

Research labs and in-person studies have been hindered by the pandemic, but brands must innovate and move forward.

The lack of federal regulation around CBD has not deterred a rush of products, some substandard. That means an open door for product companies to invest in and promote research about CBD and its efficacy, to gain market trust.

Elan Sudberg of Garden Grove, California-based Alkemist Labs, talks with Jon Benninger, VP of the Health & Nutrition Network of for Informa Markets about how smaller-scale labs prepared for the impact of COVID-19.

CBD’s entry into the supplement sphere has brought a new focus on the testing of hemp, and USDA has provided more clarity on hemp regulations before this year’s growing season. Not all testing labs are DEA sanctioned, so it’s important to make...

Just as no two people have the same DNA, there similarly are no identical approaches to personalized nutrition or supplement programs. Enter hair analysis.

CBD has taken off in the marketplace, but still misunderstood is the body’s endocannabinoid system and how it’s affected by consumer consumption of products.

Botanical firm, its personnel and community grapple with personal, cultural and professional disruptions but find solace in each other, even from a distance.